...Pauli Pöyhönen; Jouni Kuusisto; Jani Pirinen; Heli Räty; Lauri Lehmonen; Riitta Paakkanen; Nicolas Martinez-Majander; Sahrai Saeed; Eva Gerdts; Jukka Putaala; Juha Sinisalo; Vesa Järvinen Purpose: There is growing evidence that paradoxical embolism through patent foramen ovale (PFO) is a cause...

...Aakash Garg; Mohammed Thawabi; Amit Rout; Chris Sossou; Marc Cohen; John B. Kostis Efficacy of patent foramen ovale (PFO) closure in patients with cryptogenic stroke remains a matter of debate. We performed a comprehensive meta-analysis of available randomized controlled trials (RCTs) to evaluate...

...Mohammad Abdelghani; Sahar A.O. El-Shedoudy; Martina Nassif; Berto J. Bouma; Robbert J. de Winter Patent foramen ovale (PFO) is a common benign finding in healthy subjects, but its prevalence is higher in patients with stroke of unclear cause (cryptogenic stroke). PFO is believed to be associated...

... of the patent foramen ovale or atrial septal defect, with favorable results, making it the first-line therapeutic approach nowadays. Platypnea-orthodeoxia syndrome (POS) is an interesting condition with a somehow puzzling pathophysiology. There are different diseases that can cause platypnea...

...Shiva Prasad Koyalakonda; Neeraj Kumar Mediratta; Jeffrey Ball; Martin Royle Aortic valve myxoma is an extremely rare cardiac tumour. We describe a 60-year-old woman found to have an aortic valve myxoma and a patent foramen ovale (PFO) presenting as a stroke. In view of the recurrent cerebral...

... valve prolpase: long-term follow-up and aeromedical endpoints. Aviat Space Environ Med 2007;78:845–851. 17. Desai AJ, Fuller CJ, Jesurum JT, Reisman M: Patent foramen ovale and cerebrovascular diseases. Nat Clin Pract Cardiovasc Med 2006;3:446–455. 18. Overell JR, Bone I, Lees KR: Interatrial...

...Shelby Kutty; Kimberly Brown; Athar M. Qureshi; Larry A. Latson Background: We analyzed our data on patients undergoing transcatheter patent foramen ovale (PFO) closure to determine if the maximal potential PFO diameter (MPPD) by balloon sizing correlates with important clinical characteristics...

... be performed safely in patients with atrial septal aneurysms, especially in those with co-existent patent foramen ovale. 22 02 1996 3 05 1996 19 11 2008 © 1997 S. Karger AG, Basel 1997 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...

... was to determine the prevalence of NANSAID use in patients diagnosed with cryptogenic emboli or paradoxical embolic events from a patent foramen ovale (PFO) or atrial septal defect (ASD) compared with a control population with an incidental PFO/ASD and no history of embolic events. Methods: We performed...

...Annika Burow; Markus Schwerzmann; Dieter Wallmann; Hildegard Tanner; Takao Sakata; Stephan Windecker; Bernhard Meier; Etienne Delacrétaz Objectives: Recurrent embolic events after device closure of patent foramen ovale (PFO) have been related to incomplete closure. Another cause could be atrial...